Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases [0.03%]
生命早期暴露与非食管嗜酸性胃肠病发病风险的关系研究
Elizabeth T Jensen,Xiangfeng Dai,Ellyn Kodroff et al.
Elizabeth T Jensen et al.
Objectives: Early life exposures increase risk of eosinophilic esophagitis (EoE), but it is unknown whether they contribute to increased risk for non-EoE eosinophilic gastrointestinal diseases (EGIDs). We aimed to assess ...
Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer [0.03%]
肿瘤浸润淋巴细胞联合系统炎症标志物对结肠癌预后和预测价值的研究
Safa Can Efil,Gunes Guner,Deniz Can Guven et al.
Safa Can Efil et al.
Objective: Systemic inflammatory indices and CD8(+) tumor infiltrating lymphocytes (TILs) in the tumor microenvironment are highly prognostic in colon cancer (CC) but combined assessment is less well studied. The purpose ...
Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study [0.03%]
代谢手术与肝移植：现状分析——一项全国性的回顾性研究
Jérôme Dumortier,Domitille Erard,François Villeret et al.
Jérôme Dumortier et al.
At the time of the growing obesity epidemic worldwide, liver transplantation (LT) and metabolic syndrome are closely linked: non-alcohol-related fatty liver disease (NAFLD) is one of the leading indications for liver transplantation, and me...
When cirrhosis meets paroxysmal nocturnal hemoglobinuria: What kind of "fireworks" scenario will occur? [0.03%]
当肝硬化遇上阵发性夜间血红蛋白尿会碰撞出怎样的“火花”？
Xu Wang,Gui-Hua Xu,Juan Yu et al.
Xu Wang et al.
TACE plus PD-1 successfully achieves conversion therapy for unresectable HCC with multiple macrovascular invasion: Case report [0.03%]
TACE联合PD-1成功实现多根主血管侵犯不可切除肝癌的转化治疗：病例报告
Bin Guo,Yi Zhou,Zhicheng Liu et al.
Bin Guo et al.
Successful advanced hepatocellular carcinoma downstaging with atezolizumab-Bevacizumab and radioembolization before liver transplantation [0.03%]
阿特朱单抗-贝伐珠单抗和放射栓塞成功降期治疗后行肝移植的晚期肝细胞癌患者案例报告
Heloise Giudicelli,Charles Roux,Antoine Monsel et al.
Heloise Giudicelli et al.
Poor cardiorespiratory fitness may be an indicator of more severe liver inflammation in non-alcoholic fatty liver disease patients [0.03%]
不良心肺适能可能是非酒精性脂肪肝病患者更严重的肝脏炎症的标志
Luciana Carneiro Pena,Cláudia Alves Couto,Bernardo Henrique Mendes Correa et al.
Luciana Carneiro Pena et al.
Introduction: Non-alcoholic fatty liver disease (NAFLD) is related to cardiovascular disease. Cardiorespiratory fitness (CRF) is an important indicator of cardiovascular health. Therefore, we aimed to evaluate the CRF of ...
Safety and efficacy of postoperative adjuvant therapy with atezolizumab and bevacizumab after radical resection of hepatocellular carcinoma [0.03%]
阿特朱单抗与贝伐珠单抗辅助治疗完全切除的肝细胞癌后安全性及有效性的研究
Zhi-Xi Li,Qi-Fan Zhang,Jia-Ming Huang et al.
Zhi-Xi Li et al.
Background: The effects of postoperative adjuvant therapy for high-risk recurrent hepatocellular carcinoma (HCC) in immunotherapy are still under investigation. This study evaluated the preventive effects and safety of po...
Waist to height ratio in nonalcoholic fatty liver disease - Systematic review and meta-analysis [0.03%]
waist to height ratio与非酒精性脂肪肝病的关联-系统回顾及meta分析
Abdulrahman Ismaiel,Blal El Hosiny,Mohamed Ismaiel et al.
Abdulrahman Ismaiel et al.
Background and aims: Current nonalcoholic fatty liver disease (NAFLD) guidelines do not provide any recommendations regarding the waist-to-height ratio (WHtR), a simple obesity metric calculated by dividing waist circumfe...
Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study [0.03%]
基于复发时间和肿瘤大小的肝细胞癌复发的最佳治疗策略：倾向性评分匹配研究
Wenwu Wan,Hao Zhang,Tao Ji et al.
Wenwu Wan et al.
Background: Recurrent hepatocellular carcinoma (RHCC) is commonly treated with transcatheter arterial chemoembolization (TACE) combined with microwave ablation (MWA) or repeated hepatectomy(RH), but the optimal treatment ...